Company
VAXXINITY
Vaxxinity's COVID Booster Succeeds in Ph3
Also known as COVAXX
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Best-in-class, long-lasting, well tolerated, cost-effective, and effective against emerging variants with no frozen cold chain, mRNA, or spike protein.
Products
- Other
- UB-612
Loading relationship preview